| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 51, 774-778, Copyright © 1990 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JJ Gleysteen, JJ Barboriak and EA Sasse
Department of Surgery, Medical College of Wisconsin, Milwaukee.
Lipids and clinical changes including diabetes and hypertension were monitored in morbidly obese patients after Roux-Y gastric bypass. Total cholesterol (Chol), high-density-lipoprotein (HDL) cholesterol, and triglycerides at 1 and at 5-7 y postoperatively in 33 patients and at 1 y in 23 patients (including apolipoproteins A-I and B) were compared with preoperative concentrations. Mean concentrations of Chol and both apolipoproteins were unchanged. Elevated serum triglycerides became normal, and reduced concentrations persisted at 5-7 y in men (p less than 0.025). HDL-cholesterol concentrations increased at 1 y (p less than 0.01) and remained higher at 5-7 y in women. Ratios of Chol to HDL cholesterol were lower at 1 y (p less than 0.01) in both men and women. Diabetes (9 patients) and hypertension (22 patients) also were reduced at 1 y (p less than 0.01) and remained lower at 5-7 y. A mean 61% of excess weight was lost in 1 y whereas a 12% weight gain occurred by 5-7 y. The beneficial changes in most coronary risk factors lasted 5-7 y after surgery.
This article has been cited by other articles:
|
|
 |
|
  A. J. Wagner, J. M. Fabry Jr, and R. C. Thirlby Return to Work After Gastric Bypass in Medicaid-Funded Morbidly Obese Patients Arch Surg, October 1, 2007; 142(10): 935 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Shikora Severe Obesity: A Growing Health Concern A.S.P.E.N. Should Not Ignore JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4): 288 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pinkney and D. Kerrigan Review: When should bariatric surgery be used in the treatment of type 2 diabetes? The British Journal of Diabetes & Vascular Disease, July 1, 2004; 4(4): 232 - 237. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Faraj, P. J. Havel, S. Phelis, D. Blank, A. D. Sniderman, and K. Cianflone Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1594 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Livingston and A. S. Fink Quality of Life: Cost and Future of Bariatric Surgery Arch Surg, April 1, 2003; 138(4): 383 - 388. [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Brolin Bariatric Surgery and Long-term Control of Morbid Obesity JAMA, December 11, 2002; 288(22): 2793 - 2796. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Greenway, F. L. Greenway III, and S. Klein Effects of Obesity Surgery on Non-Insulin-Dependent Diabetes Mellitus Arch Surg, October 1, 2002; 137(10): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Z. Yanovski A Practical Approach to Treatment of the Obese Patient Arch Fam Med, March 1, 1993; 2(3): 309 - 316. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
